Transcriptomic signature of response to vedolizumab in patients with moderate-to-severe ulcerative colitis: Results from an international, multicentre, retrospective cohort study

被引：0
|
作者：
Linggi, B. [1 ]
Salas, A. [2 ,3 ]
Veny, M. [2 ,3 ]
Borowski, K. [4 ]
Silverberg, M. S. [4 ,5 ]
Milgrom, R. [4 ]
Stempak, J. [4 ]
Boland, B. [6 ]
Eckmann, L. [6 ]
Smith, M. I. [1 ]
Parker, C. E. [1 ]
Jairath, V. [1 ,7 ,8 ]
Teft, W. [1 ]
Vande Casteele, N. [1 ,6 ]
机构：
[1] Aliment Inc, Med Resesarch & Dev, London, ON, Canada
[2] Fundacio Recerca Clin Barcelona FRCB IDIBAPS Hosp, Inflammatory Bowel Dis Unit, Barcelona, Spain
[3] Ctr Invest Biomed Red Enfermedades Hepat & Digest, Inflammatory Bowel Dis Unit, Barcelona, Spain
[4] Sinai Hlth Syst, Zane Cohen Ctr Digest Dis, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada
[5] Univ Toronto, Div Gastroenterol, Mt Sinai Hosp, Toronto, ON, Canada
[6] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
[7] Western Univ, Dept Epidemiol & Biostat, London, ON, Canada
[8] Western Univ, Dept Med, London, ON, Canada
来源：
JOURNAL OF CROHNS & COLITIS | 2024年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
OP40
引用
收藏
页码：I71 / I71
页数：1
相关论文
共 50 条
  • [31] Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis
    Sandborn, William J.
    Feagan, Brian G.
    Marano, Colleen
    Zhang, Hongyan
    Strauss, Richard
    Johanns, Jewel
    Adedokun, Omoniyi J.
    Guzzo, Cynthia
    Colombel, Jean-Frederic
    Reinisch, Walter
    Gibson, Peter R.
    Collins, Judith
    Jarnerot, Gunnar
    Hibi, Toshifumi
    Rutgeerts, Paul
    GASTROENTEROLOGY, 2014, 146 (01) : 85 - 95
  • [32] Mirikizumab pharmacokinetics and exposure-response in pediatric patients with moderate-to-severe ulcerative colitis
    Otani, Yuki
    Chua, Laiyi
    Komocsar, Wendy J.
    Larkin, Amy
    Johns, Jordan
    Zhang, Xin
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2025, 14 (03): : 474 - 485
  • [33] Dose adjustment in patients with moderate-to-severe ulcerative colitis: results from the UNIFI maintenance study long-term extension
    Danese, S.
    Panaccione, R.
    Peyrin-Biroulet, L.
    Marano, C.
    O'Brien, C. D.
    Zhang, H.
    Zhou, Y.
    Johanns, J.
    Scherl, E.
    Leong, R. W. L.
    Rowbotham, D. S.
    Arasaradnam, R. P.
    Sands, B. E.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S403 - S403
  • [34] Efficacy of Vedolizumab and Ustekinumab Following Cyclosporine Induction in Acute Severe Ulcerative Colitis: A Retrospective Cohort Study
    Harb, M.
    Bazin, T.
    Solene, D.
    Bresteau, C.
    El Khatib, M.
    Bourdillel, J.
    Colas, C.
    Corcos, O.
    Billiauws, L.
    Joly, F.
    Nuzzo, A.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1260 - i1260
  • [35] Efficacy and safety of golimumab induction for moderate-to-severe ulcerative colitis in the United Kingdom: results from the GO-COLITIS study
    Probert, C.
    Gaya, D. R.
    Hamlin, P. J.
    Irving, P.
    Sebastian, S.
    Gillespie, G.
    Tate, H.
    Wheeler, C.
    JOURNAL OF CROHNS & COLITIS, 2016, 10 : S57 - S58
  • [36] CURRENT LANDSCAPE AND TREATMENTS USED IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS
    Siegel, C. A.
    Seigel, L.
    Verma, S.
    Sruti, I
    Mu, Q.
    Gupte, K.
    VALUE IN HEALTH, 2021, 24 : S99 - S99
  • [37] Comparative short-term effectiveness of tofacitinib and upadacitinib in refractory, moderate-to-severe ulcerative colitis - An international, multicenter cohort study
    Farkas, B.
    Resal, T.
    Lakatos, P. L.
    Limdi, J. K.
    Armuzzi, A.
    Bezzio, C.
    Savarino, E., V
    Saibeni, S.
    Michalopoulos, G.
    Attauabi, M.
    Seidelin, J. B.
    Fousekis, F. S.
    Katsanos, K.
    Bacsur, P.
    Ivany, E.
    Balint, A.
    Szepes, Z.
    Farkas, K.
    Molnar, T.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i1860 - i1861
  • [38] EFFECTIVENESS OF EARLY THIOPURINE USE IN KOREAN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE COLITIS: A PROSPECTIVE MULTICENTER COHORT (MOSAIK) STUDY
    Hyun, Hye Kyung
    Kim, Ji Won
    Lee, Jun
    Jeen, Yoon Tae
    Kim, Tae Oh
    Kim, Joo Sung
    Park, Jae Jun
    Hong, Sung Noh
    Park, Dongil
    Kim, Hyun-Soo
    Lee, Yoojin
    Jung, Eun Suk
    Kim, Youngdoe
    Jung, Su Young
    Cheon, Jae Hee
    GASTROENTEROLOGY, 2024, 166 (05) : S1424 - S1424
  • [39] Effectiveness of Early Thiopurine Use in Korean Patients with Moderate-to-Severe Ulcerative Colitis: A Prospective Multicenter Cohort (MOSAIK) study
    Hyun, H. K.
    Kim, J. W.
    Lee, J.
    Jeen, Y. T.
    Kim, T. O.
    Kim, J. S.
    Park, J. J.
    Hong, S.
    Park, D. I.
    Kim, H. S.
    Lee, Y.
    Jung, E. S.
    Kim, Y.
    Jung, S. Y.
    Cheon, J. H.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1202 - I1204
  • [40] Early course of newly diagnosed moderate-to-severe ulcerative colitis in Korea: Results from a hospital-based inception cohort study (MOSAIK)
    Yoon, Jin Young
    Cha, Jae Myung
    Lee, Chang Kyun
    Park, Young Sook
    Huh, Kyu Chan
    Shin, Jeong Eun
    Kim, You Sun
    Eun, Chang Soo
    Yoon, Soon Man
    Cheon, Jae Hee
    Park, Young Soo
    Ye, Byong Duk
    Lee, YoungJa
    Kim, Youngdoe
    Kim, Hyo Jong
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2021, 36 (08) : 2149 - 2156
12345